Insmed | 销售毛利

Gross Profit On Sales 更改 日
Dynavax Technologies USD 46.91M 9.38M 2023-12
Gilead Sciences USD 5.5B 18M 2023-12
Insmed USD 65.25M 2.88M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Insmed 销售毛利 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.